1. Home
  2. NVCR vs JKS Comparison

NVCR vs JKS Comparison

Compare NVCR & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • JKS
  • Stock Information
  • Founded
  • NVCR 2000
  • JKS 2006
  • Country
  • NVCR Switzerland
  • JKS China
  • Employees
  • NVCR N/A
  • JKS N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • JKS Semiconductors
  • Sector
  • NVCR Health Care
  • JKS Technology
  • Exchange
  • NVCR Nasdaq
  • JKS Nasdaq
  • Market Cap
  • NVCR 1.3B
  • JKS 1.2B
  • IPO Year
  • NVCR 2015
  • JKS 2010
  • Fundamental
  • Price
  • NVCR $11.25
  • JKS $30.77
  • Analyst Decision
  • NVCR Buy
  • JKS Sell
  • Analyst Count
  • NVCR 7
  • JKS 4
  • Target Price
  • NVCR $28.64
  • JKS $28.99
  • AVG Volume (30 Days)
  • NVCR 1.5M
  • JKS 883.5K
  • Earning Date
  • NVCR 10-30-2025
  • JKS 11-17-2025
  • Dividend Yield
  • NVCR N/A
  • JKS 4.91%
  • EPS Growth
  • NVCR N/A
  • JKS N/A
  • EPS
  • NVCR N/A
  • JKS N/A
  • Revenue
  • NVCR $642,269,000.00
  • JKS $9,641,756,390.00
  • Revenue This Year
  • NVCR $9.54
  • JKS N/A
  • Revenue Next Year
  • NVCR $5.70
  • JKS $31.06
  • P/E Ratio
  • NVCR N/A
  • JKS N/A
  • Revenue Growth
  • NVCR 11.17
  • JKS N/A
  • 52 Week Low
  • NVCR $10.70
  • JKS $13.42
  • 52 Week High
  • NVCR $34.13
  • JKS $31.88
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 35.05
  • JKS 65.98
  • Support Level
  • NVCR $10.70
  • JKS $25.27
  • Resistance Level
  • NVCR $12.01
  • JKS $28.25
  • Average True Range (ATR)
  • NVCR 0.57
  • JKS 2.00
  • MACD
  • NVCR -0.11
  • JKS 0.35
  • Stochastic Oscillator
  • NVCR 15.48
  • JKS 87.83

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

Share on Social Networks: